Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Regola

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|June 7, 2021
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapySilvia Piantoni, Francesca Regola, Stefania Masneri, et al.
Frontiers in Pharmacology|May 21, 2019
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With BelimumabFrancesca Regola, Silvia Piantoni, Torsten Lowin, et al.
Rheumatology (Oxford, England)|February 6, 2024
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?Laura Andreoli, Francesca Regola, Alessia Caproli, et al.
Frontiers in Medicine|February 29, 2024
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockadeSilvia Piantoni, Francesca Regola, Fabrizio Angeli, et al.
International Journal of Biometeorology|March 5, 2025
Balneotherapy in Fibromyalgia Syndrome: protocol of "FIBROTHERM", a prospective multi-center, two-cohort observational studyAlarico Ariani, Giorgio Bedogni, Giovanni Biasi, et al.
Frontiers in Immunology|September 29, 2022
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndromeLaura Naranjo, Ljudmila Stojanovich, Aleksandra Djokovic, et al.
Frontiers in Immunology|May 9, 2024
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature reviewElisa Chapuis, Elodie Bousquet, Jean-François Viallard, et al.
Orphanet Journal of Rare Diseases|March 31, 2026
Coding systems and monitoring practices across the ERN ReCONNET: insights from a comprehensive survey and unmet needsMatilde Bandeira, Diana Marinello, Sofia C Barreira, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|June 7, 2021
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapySilvia Piantoni, Francesca Regola, Stefania Masneri, et al.
Frontiers in Pharmacology|May 21, 2019
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With BelimumabFrancesca Regola, Silvia Piantoni, Torsten Lowin, et al.
Rheumatology (Oxford, England)|February 6, 2024
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?Laura Andreoli, Francesca Regola, Alessia Caproli, et al.
Frontiers in Medicine|February 29, 2024
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockadeSilvia Piantoni, Francesca Regola, Fabrizio Angeli, et al.
International Journal of Biometeorology|March 5, 2025
Balneotherapy in Fibromyalgia Syndrome: protocol of "FIBROTHERM", a prospective multi-center, two-cohort observational studyAlarico Ariani, Giorgio Bedogni, Giovanni Biasi, et al.
Frontiers in Immunology|September 29, 2022
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndromeLaura Naranjo, Ljudmila Stojanovich, Aleksandra Djokovic, et al.
Frontiers in Immunology|May 9, 2024
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature reviewElisa Chapuis, Elodie Bousquet, Jean-François Viallard, et al.
Orphanet Journal of Rare Diseases|March 31, 2026
Coding systems and monitoring practices across the ERN ReCONNET: insights from a comprehensive survey and unmet needsMatilde Bandeira, Diana Marinello, Sofia C Barreira, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Pageof 3